"ASXL1"-erating inflammation and bone marrow fibrosis in myeloproliferative neoplasms
- PMID: 36005565
- PMCID: PMC10153523
- DOI: 10.3324/haematol.2022.281634
"ASXL1"-erating inflammation and bone marrow fibrosis in myeloproliferative neoplasms
Comment on
-
ASXL1 mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms.Haematologica. 2023 May 1;108(5):1359-1373. doi: 10.3324/haematol.2021.280320. Haematologica. 2023. PMID: 36005555 Free PMC article.
References
-
- Boiocchi L, Espinal-Witter R, Geyer JT, et al. Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease. Mod Pathol. 3013;26(2):204-212. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
